Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.
Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.
复制标题
DOI:
10.1161/hypertensionaha.120.16118
复制
发表时间:
2020-12
期刊:
影响因子:
--
通讯作者:
Rafikova O
中科院分区:
文献类型:
--
作者:
Zemskova M;McClain N;Niihori M;Varghese MV;James J;Rafikov R;Rafikova O
Damage-associated molecular patterns, such as HMGB1, play a well-recognized role in the development of pulmonary arterial hypertension (PAH), a progressive fatal disease of the pulmonary vasculature. However, the contribution of the particular type of vascular cells, type of cell death, or the form of released HMGB1 in PAH remains unclear. Moreover, although male PAH patients show a higher level of circulating HMGB1, its involvement in the severe PAH phenotype reported in males is unknown. In this study, we aimed to investigate the sources and active forms of HMGB1 released from damaged vascular cells and their contribution to the progressive type of PAH in males. Our results showed that HMGB1 is released by either pulmonary artery human endothelial (HPAEC) or human smooth muscle cells (HPASMC) that underwent necrotic cell death, although only HPASMC produce HMGB1 during apoptosis. Moreover, only HPASMC death induced a release of dimeric HMGB1, found to be mitochondrial reactive oxygen species dependent, and TLR4 activation. The modified Sugen/Hypoxia rat model replicates the human sexual dimorphism in PAH severity (right ventricle systolic pressure in males vs. females 54.7±2.3 vs. 44.6±2 mmHg). By using this model, we confirmed that necroptosis and necrosis are the primary sources of circulating HMGB1 in the male rats, although only necrosis increased circulation of HMGB1 dimers. Attenuation of necrosis but not apoptosis or necroptosis prevented TLR4 activation in males and blunted the sex differences in PAH severity. We conclude that necrosis, through the release of HMGB1 dimers, predisposes males to a progressive form of PAH. HMGB1 release and activity depend on the type of vascular cells, type of cell death, and form of released HMGB1. HMGB1 released from necrotic cells promotes PAH severity in male rodents in the preclinical model of PAH, suggesting its involvement in progressive PAH and poor survival prognosis in male patients with PAH.